Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) shares fell 5.9% during trading on Friday . The stock traded as low as $0.51 and last traded at $0.52. 228,991 shares were traded during mid-day trading, an increase of 29% from the average session volume of 177,759 shares. The stock had previously closed at $0.55.
Orgenesis Price Performance
The firm’s 50-day moving average is $0.70 and its 200 day moving average is $0.64.
Orgenesis (NASDAQ:ORGS – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported ($0.23) EPS for the quarter. The company had revenue of $0.25 million for the quarter.
Orgenesis Company Profile
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Featured Stories
- Five stocks we like better than Orgenesis
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is the Australian Securities Exchange (ASX)
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Using the MarketBeat Dividend Tax Calculator
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
-inc-logo-1200x675.PNG?v=20210312142656&h=45&w=95&zc=2){kind=logo}
